Page last updated: 2024-08-23

cabergoline and Disorders of Excessive Somnolence

cabergoline has been researched along with Disorders of Excessive Somnolence in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernardini, S; Berti, C; Bonuccelli, U; Caneparo, D; Del Dotto, P; Gambaccini, G1
Agapito, C; Bhattacharya, KF; Chaudhuri, KR; Pal, S1

Other Studies

2 other study(ies) available for cabergoline and Disorders of Excessive Somnolence

ArticleYear
Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2003, Volume: 24, Issue:3

    Topics: Aged; Antiparkinson Agents; Cabergoline; Disorders of Excessive Somnolence; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Ergolines; Female; Humans; Male; Mental Status Schedule; Middle Aged; Parkinson Disease; Pilot Projects; Prospective Studies; Psychomotor Performance; Time Factors

2003
A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy.
    Journal of neural transmission (Vienna, Austria : 1996), 2001, Volume: 108, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cabergoline; Disorders of Excessive Somnolence; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Retrospective Studies; Thiazoles

2001